Literature DB >> 22217127

A pilot study of the nutritional status of opiate-using pregnant women on methadone maintenance therapy.

Laura Elizabeth Tomedi1, Debra L Bogen, Barbara H Hanusa, Katherine L Wisner, Lisa M Bodnar.   

Abstract

Pregnant women in methadone maintenance therapy may have poor nutrition during pregnancy. In 2006-2008, methadone-treated pregnant women (n = 22) were recruited at an urban academic medical center and compared with nondrug-using pregnant women (n = 119) at 20-35 weeks' gestation. We measured adiposity using prepregnancy body mass index (BMI), dietary intake using a food frequency questionnaire, and micronutrient and essential fatty acid status using biomarkers. Methadone-treated women had lower BMI, consumed more calories, had lower serum carotenoid concentrations, and higher plasma homocysteine concentrations than controls. The study's limitations and implications for future research are discussed.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22217127      PMCID: PMC3257808          DOI: 10.3109/10826084.2011.635324

Source DB:  PubMed          Journal:  Subst Use Misuse        ISSN: 1082-6084            Impact factor:   2.164


  45 in total

1.  High sugar consumption and poor nutrient intake among drug addicts in Oslo, Norway.

Authors:  M Saeland; M Haugen; F-L Eriksen; M Wandel; A Smehaugen; T Böhmer; A Oshaug
Journal:  Br J Nutr       Date:  2010-09-30       Impact factor: 3.718

2.  Characteristics of pregnant illicit drug users and associations between cannabis use and perinatal outcome in a population-based study.

Authors:  Marleen M H J van Gelder; Jennita Reefhuis; Alissa R Caton; Martha M Werler; Charlotte M Druschel; Nel Roeleveld
Journal:  Drug Alcohol Depend       Date:  2010-02-18       Impact factor: 4.492

3.  Risk factors for preterm birth among opiate-addicted gravid women in a methadone treatment program.

Authors:  Christopher V Almario; Neil S Seligman; Kevin C Dysart; Vincenzo Berghella; Jason K Baxter
Journal:  Am J Obstet Gynecol       Date:  2009-07-24       Impact factor: 8.661

4.  Pregnancy outcome in women who use opiates.

Authors:  O Fajemirokun-Odudeyi; C Sinha; S Tutty; P Pairaudeau; D Armstrong; T Phillips; S W Lindow
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2005-10-03       Impact factor: 2.435

5.  High prevalence of vitamin D insufficiency in black and white pregnant women residing in the northern United States and their neonates.

Authors:  Lisa M Bodnar; Hyagriv N Simhan; Robert W Powers; Michael P Frank; Emily Cooperstein; James M Roberts
Journal:  J Nutr       Date:  2007-02       Impact factor: 4.798

6.  Major depression and antidepressant treatment: impact on pregnancy and neonatal outcomes.

Authors:  Katherine L Wisner; Dorothy K Y Sit; Barbara H Hanusa; Eydie L Moses-Kolko; Debra L Bogen; Diane F Hunker; James M Perel; Sonya Jones-Ivy; Lisa M Bodnar; Lynn T Singer
Journal:  Am J Psychiatry       Date:  2009-03-16       Impact factor: 18.112

7.  Universal screening for substance abuse at the time of parturition.

Authors:  Ali Azadi; Gary A Dildy
Journal:  Am J Obstet Gynecol       Date:  2008-02-14       Impact factor: 8.661

8.  Illicit drug use and adverse birth outcomes: is it drugs or context?

Authors:  Ashley H Schempf; Donna M Strobino
Journal:  J Urban Health       Date:  2008-09-15       Impact factor: 3.671

Review 9.  Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence.

Authors:  Richard P Mattick; Courtney Breen; Jo Kimber; Marina Davoli
Journal:  Cochrane Database Syst Rev       Date:  2009-07-08

10.  Factors associated with substance use during pregnancy: results from a national sample.

Authors:  Jennifer R Havens; Leigh Ann Simmons; Lisa M Shannon; Wendy F Hansen
Journal:  Drug Alcohol Depend       Date:  2008-09-07       Impact factor: 4.492

View more
  4 in total

1.  Dietary Intake Among Opioid- and Alcohol-Using Pregnant Women.

Authors:  Shikhar Shrestha; Elizabeth Jimenez; Laura Garrison; Peter Pribis; Dennis W Raisch; Julia M Stephen; Ludmila N Bakhireva
Journal:  Subst Use Misuse       Date:  2017-02-22       Impact factor: 2.164

2.  Folate Status as a Nutritional Indicator among People with Substance Use Disorder; A Prospective Cohort Study in Norway.

Authors:  Mitra Bemanian; Jørn Henrik Vold; Ranadip Chowdhury; Christer Frode Aas; Rolf Gjestad; Kjell Arne Johansson; Lars Thore Fadnes
Journal:  Int J Environ Res Public Health       Date:  2022-05-09       Impact factor: 4.614

3.  Pharmacologic evidence to support clinical decision making for peripartum methadone treatment.

Authors:  D L Bogen; J M Perel; J C Helsel; B H Hanusa; M Romkes; T Nukui; C R Friedman; K L Wisner
Journal:  Psychopharmacology (Berl)       Date:  2012-08-25       Impact factor: 4.530

4.  Comparison between Homocysteine, Fibrinogen, PT, PTT, INR and CRP in Male Smokers with/without Addiction to Opium.

Authors:  Nahid Azdaki; Mahmood Zardast; Gholamreza Anani-Sarab; Hamid Abdorrazaghnaejad; Mohammad Reza Ghasemian; Amin Saburi
Journal:  Addict Health       Date:  2017-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.